Utah residents can now renew prescriptions online through Doctronic, an AI chatbot launched under a state regulatory sandbox that bypasses a traditional doctor visit.
190 medications are eligible for refill, though human doctors still review every order for now; the company says it expects to move soon to fully automated renewals.
11 members of Utah’s medical licensing board urged the state in March to halt the program, warning that drugs such as blood thinners can become unsafe when patients’ conditions change.
500 telehealth records underpin the company’s main published evidence, an unreviewed study in which Doctronic’s diagnoses matched human doctors 80% of the time.
Federal oversight remains unclear: experts say FDA rules may apply to AI making medical decisions, but the agency has not authorized any chatbots and is taking a largely hands-off stance.
With studies revealing frequent AI medical errors, how can patients trust automated systems with their health?
As states create a patchwork of AI health laws, who is ultimately accountable when an algorithm makes a mistake?
Pioneering AI in Healthcare: Utah’s 200-Drug Prescription Renewal Pilot Sparks National Debate on Safety and Oversight
Overview
In January 2026, Utah became the first state in the U.S. to launch an AI pilot program allowing a chatbot to autonomously renew prescriptions for nearly 200 drugs. This initiative, created through an agreement between Utah’s Office of Artificial Intelligence Policy and the startup Doctronic, aimed to put advanced AI at the center of medication management. However, the Utah Medical Licensing Board was not consulted before the launch and responded with immediate backlash, expressing serious concerns about patient safety and regulatory oversight. The controversy quickly sparked a broader debate about the role of AI in healthcare and the need for clear guidelines.